These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17453534)

  • 1. Early pharmacological treatment of acute heart failure syndromes: a systematic review of clinical trials.
    De Luca L; Fonarow GC; Mebazaa A; Shin DD; Collins SP; Swedberg K; Gheorghiade M
    Acute Card Care; 2007; 9(1):10-21. PubMed ID: 17453534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of current and investigational pharmacologic agents for acute heart failure syndromes.
    Shin DD; Brandimarte F; De Luca L; Sabbah HN; Fonarow GC; Filippatos G; Komajda M; Gheorghiade M
    Am J Cardiol; 2007 Jan; 99(2A):4A-23A. PubMed ID: 17239703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian adaptive trial design in acute heart failure syndromes: moving beyond the mega trial.
    Collins SP; Lindsell CJ; Pang PS; Storrow AB; Peacock WF; Levy P; Rahbar MH; Del Junco D; Gheorghiade M; Berry DA
    Am Heart J; 2012 Aug; 164(2):138-45. PubMed ID: 22877798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase.
    Gheorghiade M; Pang PS; O'Connor CM; Prasad K; McMurray J; Teerlink JR; Fiuzat M; Sabbah H; Komajda M
    Am Heart J; 2011 Feb; 161(2):224-32. PubMed ID: 21315202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New investigational drugs for the management of acute heart failure syndromes.
    Tamargo J; Amorós I; Barana A; Caballero R; Delpón E
    Curr Med Chem; 2010; 17(4):363-90. PubMed ID: 20015042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes.
    Tamargo J; Rosano GM; Delpón E; Ruilope L; López-Sendón J
    Int J Cardiol; 2017 Apr; 233():1-11. PubMed ID: 28161130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of emerging pharmacologic agents for acute heart failure syndromes.
    De Luca L; Mebazaa A; Filippatos G; Parissis JT; Böhm M; Voors AA; Nieminen M; Zannad F; Rhodes A; El-Banayosy A; Dickstein K; Gheorghiade M
    Eur J Heart Fail; 2008 Feb; 10(2):201-13. PubMed ID: 18279775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rationale for an acute heart failure syndromes clinical trials network.
    Collins SP; Levy PD; Lindsell CJ; Pang PS; Storrow AB; Miller CD; Naftilan AJ; Thohan V; Abraham WT; Hiestand B; Filippatos G; Diercks DB; Hollander J; Nowak R; Peacock WF; Gheorghiade M
    J Card Fail; 2009 Aug; 15(6):467-74. PubMed ID: 19643356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of phase II acute heart failure syndromes clinical trials.
    Pang PS; Gheorghiade M
    Heart Fail Clin; 2011 Oct; 7(4):441-50. PubMed ID: 21925427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
    Bayram M; De Luca L; Massie MB; Gheorghiade M
    Am J Cardiol; 2005 Sep; 96(6A):47G-58G. PubMed ID: 16181823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of randomized clinical trials in acute heart failure syndromes.
    Teerlink JR
    Am J Cardiol; 2005 Sep; 96(6A):59G-67G. PubMed ID: 16181824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of acute heart failure syndromes.
    Alla F; Zannad F; Filippatos G
    Heart Fail Rev; 2007 Jun; 12(2):91-5. PubMed ID: 17450426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data.
    Sato N; Kajimoto K; Asai K; Mizuno M; Minami Y; Nagashima M; Murai K; Muanakata R; Yumino D; Meguro T; Kawana M; Nejima J; Satoh T; Mizuno K; Tanaka K; Kasanuki H; Takano T;
    Am Heart J; 2010 Jun; 159(6):949-955.e1. PubMed ID: 20569705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rational use of catecholamines and inotropes].
    Hewing B; Stangl K
    Pneumologie; 2007 Nov; 61(11):700-8. PubMed ID: 17929214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End points for clinical trials in acute heart failure syndromes.
    Allen LA; Hernandez AF; O'Connor CM; Felker GM
    J Am Coll Cardiol; 2009 Jun; 53(24):2248-58. PubMed ID: 19520247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).
    Gheorghiade M; Gattis Stough W; Adams KF; Jaffe AS; Hasselblad V; O'Connor CM
    Am J Cardiol; 2005 Sep; 96(6A):18G-25G. PubMed ID: 16181819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment.
    Flaherty JD; Bax JJ; De Luca L; Rossi JS; Davidson CJ; Filippatos G; Liu PP; Konstam MA; Greenberg B; Mehra MR; Breithardt G; Pang PS; Young JB; Fonarow GC; Bonow RO; Gheorghiade M;
    J Am Coll Cardiol; 2009 Jan; 53(3):254-63. PubMed ID: 19147042
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.